Analysis of Serum Haptoglobin Fucosylation in Hepatocellular Carcinoma and Liver Cirrhosis of Different Etiologies

We have developed herein a quantitative mass spectrometry-based approach to analyze the etiology-related alterations in fucosylation degree of serum haptoglobin in patients with liver cirrhosis and hepatocellular carcinoma (HCC). The three most common etiologies, including infection with hepatitis B...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of proteome research Jg. 13; H. 6; S. 2986 - 2997
Hauptverfasser: Zhu, Jianhui, Lin, Zhenxin, Wu, Jing, Yin, Haidi, Dai, Jianliang, Feng, Ziding, Marrero, Jorge, Lubman, David M
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States American Chemical Society 06.06.2014
Schlagworte:
ISSN:1535-3893, 1535-3907, 1535-3907
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract We have developed herein a quantitative mass spectrometry-based approach to analyze the etiology-related alterations in fucosylation degree of serum haptoglobin in patients with liver cirrhosis and hepatocellular carcinoma (HCC). The three most common etiologies, including infection with hepatitis B virus (HBV), infection with hepatitis C virus (HCV), and heavy alcohol consumption (ALC), were investigated. Only 10 μL of serum was used in this assay in which haptoglobin was immunoprecipitated using a monoclonal antibody. The N-glycans of haptoglobin were released with PNGase F, desialylated, and permethylated prior to MALDI-QIT-TOF MS analysis. In total, N-glycan profiles derived from 104 individual patient samples were quantified (14 healthy controls, 40 cirrhosis, and 50 HCCs). A unique pattern of bifucosylated tetra-antennary glycan, with both core and antennary fucosylation, was identified in HCC patients. Quantitative analysis indicated that the increased fucosylation degree was highly associated with HBV- and ALC-related HCC patients compared to that of the corresponding cirrhosis patients. Notably, the bifucosylation degree was distinctly increased in HCC patients versus that in cirrhosis of all etiologies. The elevated bifucosylation degree of haptoglobin can discriminate early stage HCC patients from cirrhosis in each etiologic category, which may be used to provide a potential marker for early detection and to predict HCC in patients with cirrhosis.
AbstractList We have developed herein a quantitative mass spectrometry-based approach to analyze the etiology-related alterations in fucosylation degree of serum haptoglobin in patients with liver cirrhosis and hepatocellular carcinoma (HCC). The three most common etiologies, including infection with hepatitis B virus (HBV), infection with hepatitis C virus (HCV), and heavy alcohol consumption (ALC), were investigated. Only 10 μL of serum was used in this assay in which haptoglobin was immunoprecipitated using a monoclonal antibody. The N-glycans of haptoglobin were released with PNGase F, desialylated, and permethylated prior to MALDI-QIT-TOF MS analysis. In total, N-glycan profiles derived from 104 individual patient samples were quantified (14 healthy controls, 40 cirrhosis, and 50 HCCs). A unique pattern of bifucosylated tetra-antennary glycan, with both core and antennary fucosylation, was identified in HCC patients. Quantitative analysis indicated that the increased fucosylation degree was highly associated with HBV- and ALC-related HCC patients compared to that of the corresponding cirrhosis patients. Notably, the bifucosylation degree was distinctly increased in HCC patients versus that in cirrhosis of all etiologies. The elevated bifucosylation degree of haptoglobin can discriminate early stage HCC patients from cirrhosis in each etiologic category, which may be used to provide a potential marker for early detection and to predict HCC in patients with cirrhosis.
We have developed herein a quantitative mass spectrometry-based approach to analyze the etiology-related alterations in fucosylation degree of serum haptoglobin in patients with liver cirrhosis and hepatocellular carcinoma (HCC). The three most common etiologies, including infection with hepatitis B virus (HBV), infection with hepatitis C virus (HCV), and heavy alcohol consumption (ALC), were investigated. Only 10 μL of serum was used in this assay in which haptoglobin was immunoprecipitated using a monoclonal antibody. The N-glycans of haptoglobin were released with PNGase F, desialylated, and permethylated prior to MALDI-QIT-TOF MS analysis. In total, N-glycan profiles derived from 104 individual patient samples were quantified (14 healthy controls, 40 cirrhosis, and 50 HCCs). A unique pattern of bifucosylated tetra-antennary glycan, with both core and antennary fucosylation, was identified in HCC patients. Quantitative analysis indicated that the increased fucosylation degree was highly associated with HBV- and ALC-related HCC patients compared to that of the corresponding cirrhosis patients. Notably, the bifucosylation degree was distinctly increased in HCC patients versus that in cirrhosis of all etiologies. The elevated bifucosylation degree of haptoglobin can discriminate early stage HCC patients from cirrhosis in each etiologic category, which may be used to provide a potential marker for early detection and to predict HCC in patients with cirrhosis.We have developed herein a quantitative mass spectrometry-based approach to analyze the etiology-related alterations in fucosylation degree of serum haptoglobin in patients with liver cirrhosis and hepatocellular carcinoma (HCC). The three most common etiologies, including infection with hepatitis B virus (HBV), infection with hepatitis C virus (HCV), and heavy alcohol consumption (ALC), were investigated. Only 10 μL of serum was used in this assay in which haptoglobin was immunoprecipitated using a monoclonal antibody. The N-glycans of haptoglobin were released with PNGase F, desialylated, and permethylated prior to MALDI-QIT-TOF MS analysis. In total, N-glycan profiles derived from 104 individual patient samples were quantified (14 healthy controls, 40 cirrhosis, and 50 HCCs). A unique pattern of bifucosylated tetra-antennary glycan, with both core and antennary fucosylation, was identified in HCC patients. Quantitative analysis indicated that the increased fucosylation degree was highly associated with HBV- and ALC-related HCC patients compared to that of the corresponding cirrhosis patients. Notably, the bifucosylation degree was distinctly increased in HCC patients versus that in cirrhosis of all etiologies. The elevated bifucosylation degree of haptoglobin can discriminate early stage HCC patients from cirrhosis in each etiologic category, which may be used to provide a potential marker for early detection and to predict HCC in patients with cirrhosis.
Author Wu, Jing
Dai, Jianliang
Marrero, Jorge
Feng, Ziding
Lubman, David M
Lin, Zhenxin
Zhu, Jianhui
Yin, Haidi
AuthorAffiliation Department of Biostatistics
University of Texas MD Anderson Cancer Center
UT Southwestern Medical Center
University of Michigan Medical Center
Department of Internal Medicine
Department of Surgery
AuthorAffiliation_xml – name: University of Texas MD Anderson Cancer Center
– name: Department of Biostatistics
– name: Department of Surgery
– name: Department of Internal Medicine
– name: University of Michigan Medical Center
– name: UT Southwestern Medical Center
Author_xml – sequence: 1
  givenname: Jianhui
  surname: Zhu
  fullname: Zhu, Jianhui
– sequence: 2
  givenname: Zhenxin
  surname: Lin
  fullname: Lin, Zhenxin
– sequence: 3
  givenname: Jing
  surname: Wu
  fullname: Wu, Jing
– sequence: 4
  givenname: Haidi
  surname: Yin
  fullname: Yin, Haidi
– sequence: 5
  givenname: Jianliang
  surname: Dai
  fullname: Dai, Jianliang
– sequence: 6
  givenname: Ziding
  surname: Feng
  fullname: Feng, Ziding
– sequence: 7
  givenname: Jorge
  surname: Marrero
  fullname: Marrero, Jorge
– sequence: 8
  givenname: David M
  surname: Lubman
  fullname: Lubman, David M
  email: dmlubman@umich.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24807840$$D View this record in MEDLINE/PubMed
BookMark eNo9kE1Lw0AQQBep2A89-AdkL4KX6H4kZnMstbVCwYO9h0kyqVuS3bibCP33bmnraWeHx2N4UzIy1iAh95w9cyb4S-cSxrhQ_RWZ8EQmkcxYOrrMKpNjMvV-H5gkZfKGjEWsWKpiNiFubqA5eO2prekXuqGla-h6u2tsoQ1dDaX1hwZ6bQ0N_zV20NsSm2ZowNEFuFIb2wIFU9GN_sWw085927PxTdc1OjQ9XQZFY3ca_S25rqHxeHd-Z2S7Wm4X62jz-f6xmG8iSFjcR5ynouIZcpFlUlQSkljIgmOlIOMgqkQWr1IiIlOyVFLFSqBSNUtrLlAUckaeTtrO2Z8BfZ-32h8vB4N28HmIE_NQLZYBfTijQ9FilXdOt-AO-SVTAB5PAJQ-39vBhWjBwPJj_vw_v_wD7uZ3MQ
CitedBy_id crossref_primary_10_1039_C9SC00360F
crossref_primary_10_3389_fonc_2023_1213898
crossref_primary_10_3390_metabo11080563
crossref_primary_10_3389_fnins_2022_1000179
crossref_primary_10_1016_j_cej_2023_144016
crossref_primary_10_3389_fonc_2022_822449
crossref_primary_10_3390_ijms231911113
crossref_primary_10_1016_j_cld_2020_07_001
crossref_primary_10_1007_s00216_016_9878_0
crossref_primary_10_1016_j_cca_2019_04_072
crossref_primary_10_1016_j_jprot_2016_09_004
crossref_primary_10_1002_jimd_12273
crossref_primary_10_1016_j_clinre_2019_12_010
crossref_primary_10_3390_app10238401
crossref_primary_10_1515_cclm_2018_0379
crossref_primary_10_1007_s10719_018_9838_3
crossref_primary_10_1007_s12011_015_0309_4
crossref_primary_10_7841_ksbbj_2017_32_4_279
crossref_primary_10_3389_fchem_2020_00138
crossref_primary_10_3748_wjg_v28_i29_3780
crossref_primary_10_1186_s12885_023_10511_3
crossref_primary_10_1002_jms_4432
crossref_primary_10_1016_j_trsl_2024_05_008
crossref_primary_10_1007_s12562_024_01804_y
crossref_primary_10_1016_j_talanta_2015_07_045
crossref_primary_10_1002_elps_201700084
crossref_primary_10_1016_j_gendis_2025_101570
crossref_primary_10_1016_j_virusres_2017_06_003
crossref_primary_10_1038_srep27965
crossref_primary_10_1038_s43856_024_00677_7
crossref_primary_10_1111_apt_17748
crossref_primary_10_1016_j_carres_2016_09_009
crossref_primary_10_1002_mas_21707
crossref_primary_10_1016_j_jpba_2017_04_040
crossref_primary_10_3389_fonc_2022_818001
crossref_primary_10_1016_j_bbagen_2019_03_001
crossref_primary_10_3390_cancers12010239
crossref_primary_10_1007_s10719_019_09906_x
crossref_primary_10_18097_PBMCR1552
crossref_primary_10_1093_glycob_cww016
crossref_primary_10_1080_14789450_2019_1626235
crossref_primary_10_1371_journal_pone_0173897
crossref_primary_10_1016_j_bbrc_2023_06_017
crossref_primary_10_1002_mas_21583
crossref_primary_10_1007_s00216_018_1418_7
crossref_primary_10_1007_s10719_016_9653_7
crossref_primary_10_1038_srep33927
crossref_primary_10_1016_j_mam_2020_100851
crossref_primary_10_1016_j_talanta_2023_125527
crossref_primary_10_1038_s41388_023_02702_w
crossref_primary_10_3390_cancers11091241
crossref_primary_10_1007_s00216_016_9570_4
crossref_primary_10_1016_j_bbrc_2016_05_027
crossref_primary_10_3390_molecules28031293
crossref_primary_10_1080_14789450_2023_2265064
crossref_primary_10_1002_mas_21718
crossref_primary_10_3390_biom13091369
crossref_primary_10_1038_s41392_024_01886_1
crossref_primary_10_1038_s41598_019_56947_1
crossref_primary_10_1073_pnas_1807439115
crossref_primary_10_1016_j_canlet_2017_07_026
crossref_primary_10_2217_hep_2017_0019
crossref_primary_10_1080_14789450_2018_1543594
crossref_primary_10_1016_j_bbapap_2016_02_017
crossref_primary_10_1016_j_mcpro_2024_100876
crossref_primary_10_2174_1875318301909010031
crossref_primary_10_1016_j_envpol_2020_115774
crossref_primary_10_1002_elps_201700025
crossref_primary_10_1007_s00595_015_1299_8
crossref_primary_10_1016_j_bbagen_2016_03_012
crossref_primary_10_1007_s10719_015_9626_2
crossref_primary_10_1053_j_gastro_2019_08_060
crossref_primary_10_1002_elps_201600176
crossref_primary_10_1038_s41598_019_48043_1
ContentType Journal Article
Copyright Copyright © 2014 American Chemical Society
Copyright_xml – notice: Copyright © 2014 American Chemical Society
DBID N~.
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1021/pr500128t
DatabaseName American Chemical Society (ACS) Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: N~.
  name: American Chemical Society (ACS) Open Access
  url: https://pubs.acs.org
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1535-3907
EndPage 2997
ExternalDocumentID 24807840
b904997066
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: 1R01 CA154455
– fundername: NCI NIH HHS
  grantid: R01 CA154455
– fundername: NCI NIH HHS
  grantid: P30 CA016672
– fundername: NCI NIH HHS
  grantid: R01 CA160254
– fundername: NIGMS NIH HHS
  grantid: R01 GM049500
– fundername: NCI NIH HHS
  grantid: 1R01 CA160254
– fundername: NIGMS NIH HHS
  grantid: R01 GM 49500
GroupedDBID -
4.4
53G
55A
5GY
7~N
AABXI
ABMVS
ABUCX
ACGFS
ACS
AEESW
AENEX
AFEFF
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
CS3
DU5
EBS
ED
ED~
EJD
F5P
GNL
IH9
IHE
JG
JG~
LG6
N~.
P2P
RNS
ROL
UI2
VF5
VG9
W1F
ZA5
---
5VS
AAHBH
ABBLG
ABJNI
ABLBI
ABQRX
ADHLV
AHGAQ
BAANH
CGR
CUPRZ
CUY
CVF
ECM
EIF
GGK
NPM
7X8
ID FETCH-LOGICAL-a504t-1172d19e129932d3a5423b1ed8a91a2d53b633eee083c838482e88f07f12e2b3
IEDL.DBID N~.
ISICitedReferencesCount 107
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000337074500025&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1535-3893
1535-3907
IngestDate Thu Jul 10 22:40:19 EDT 2025
Mon Jul 21 05:54:44 EDT 2025
Thu Aug 27 13:42:25 EDT 2020
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords fucosylation
Hepatocellular carcinoma
biomarker
haptoglobin
MALDI
liver cirrhosis
Language English
License http://pubs.acs.org/page/policy/authorchoice_termsofuse.html
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a504t-1172d19e129932d3a5423b1ed8a91a2d53b633eee083c838482e88f07f12e2b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1021/pr500128t
PMID 24807840
PQID 1534101243
PQPubID 23479
PageCount 12
ParticipantIDs proquest_miscellaneous_1534101243
pubmed_primary_24807840
acs_journals_10_1021_pr500128t
ProviderPackageCode JG~
55A
AABXI
GNL
VF5
7~N
VG9
W1F
ACS
AEESW
AFEFF
ABMVS
ABUCX
IH9
AQSVZ
ED~
N~.
UI2
PublicationCentury 2000
PublicationDate 2014-06-06
PublicationDateYYYYMMDD 2014-06-06
PublicationDate_xml – month: 06
  year: 2014
  text: 2014-06-06
  day: 06
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of proteome research
PublicationTitleAlternate J. Proteome Res
PublicationYear 2014
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References 17022640 - J Proteome Res. 2006 Oct;5(10):2691-700
24057163 - J Gastroenterol. 2014 Mar;49(3):555-63
19673623 - Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):353-67
23666731 - Methods Mol Biol. 2013;1007:289-300
16252310 - Rapid Commun Mass Spectrom. 2005;19(23):3421-8
18617146 - J Proteomics. 2008 Jul 21;71(2):186-97
17683101 - Hepatology. 2007 Nov;46(5):1426-35
21417406 - J Proteome Res. 2011 May 6;10(5):2602-11
17698430 - J Chin Med Assoc. 2007 Aug;70(8):310-7
21380457 - Mol Biosyst. 2011 May;7(5):1621-8
17803183 - Int J Cancer. 2008 Jan 1;122(1):39-49
16385567 - Int J Cancer. 2006 Jun 1;118(11):2803-8
6997877 - Proc Natl Acad Sci U S A. 1980 Jun;77(6):3388-92
18628926 - Proc (Bayl Univ Med Cent). 2008 Jul;21(3):266-80
21115577 - Oncologist. 2010;15 Suppl 4:14-22
19551866 - Int J Cancer. 2010 Jan 1;126(1):142-55
17288606 - BMC Cancer. 2007;7:28
19099421 - J Proteome Res. 2009 Feb;8(2):595-602
19454616 - Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1914-21
11694234 - Clin Chim Acta. 2001 Nov;313(1-2):15-9
23389048 - Mol Cell Proteomics. 2013 May;12(5):1294-305
9352226 - Eur J Clin Chem Clin Biochem. 1997 Sep;35(9):647-54
12394209 - J Clin Gastroenterol. 2002 Nov-Dec;35(5 Suppl 2):S72-8
References_xml – reference: 17803183 - Int J Cancer. 2008 Jan 1;122(1):39-49
– reference: 19454616 - Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1914-21
– reference: 21417406 - J Proteome Res. 2011 May 6;10(5):2602-11
– reference: 19099421 - J Proteome Res. 2009 Feb;8(2):595-602
– reference: 18617146 - J Proteomics. 2008 Jul 21;71(2):186-97
– reference: 12394209 - J Clin Gastroenterol. 2002 Nov-Dec;35(5 Suppl 2):S72-8
– reference: 21115577 - Oncologist. 2010;15 Suppl 4:14-22
– reference: 19551866 - Int J Cancer. 2010 Jan 1;126(1):142-55
– reference: 18628926 - Proc (Bayl Univ Med Cent). 2008 Jul;21(3):266-80
– reference: 17698430 - J Chin Med Assoc. 2007 Aug;70(8):310-7
– reference: 24057163 - J Gastroenterol. 2014 Mar;49(3):555-63
– reference: 19673623 - Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):353-67
– reference: 23389048 - Mol Cell Proteomics. 2013 May;12(5):1294-305
– reference: 11694234 - Clin Chim Acta. 2001 Nov;313(1-2):15-9
– reference: 6997877 - Proc Natl Acad Sci U S A. 1980 Jun;77(6):3388-92
– reference: 21380457 - Mol Biosyst. 2011 May;7(5):1621-8
– reference: 17683101 - Hepatology. 2007 Nov;46(5):1426-35
– reference: 16252310 - Rapid Commun Mass Spectrom. 2005;19(23):3421-8
– reference: 17022640 - J Proteome Res. 2006 Oct;5(10):2691-700
– reference: 23666731 - Methods Mol Biol. 2013;1007:289-300
– reference: 17288606 - BMC Cancer. 2007;7:28
– reference: 9352226 - Eur J Clin Chem Clin Biochem. 1997 Sep;35(9):647-54
– reference: 16385567 - Int J Cancer. 2006 Jun 1;118(11):2803-8
SSID ssj0015703
Score 2.447902
Snippet We have developed herein a quantitative mass spectrometry-based approach to analyze the etiology-related alterations in fucosylation degree of serum...
SourceID proquest
pubmed
acs
SourceType Aggregation Database
Index Database
Publisher
StartPage 2986
SubjectTerms Aged
Alcohol Drinking - adverse effects
Biomarkers, Tumor - blood
Carbohydrate Conformation
Carbohydrate Sequence
Carcinoma, Hepatocellular - blood
Carcinoma, Hepatocellular - diagnosis
Carcinoma, Hepatocellular - etiology
Case-Control Studies
Diagnosis, Differential
Early Detection of Cancer
Female
Fucose - metabolism
Glycosylation
Haptoglobins - metabolism
Hepatitis B - blood
Hepatitis B - complications
Hepatitis C - blood
Hepatitis C - complications
Humans
Liver Cirrhosis - blood
Liver Cirrhosis - diagnosis
Liver Cirrhosis - etiology
Liver Neoplasms - blood
Liver Neoplasms - diagnosis
Liver Neoplasms - etiology
Male
Middle Aged
Molecular Sequence Data
Protein Processing, Post-Translational
Title Analysis of Serum Haptoglobin Fucosylation in Hepatocellular Carcinoma and Liver Cirrhosis of Different Etiologies
URI http://dx.doi.org/10.1021/pr500128t
https://www.ncbi.nlm.nih.gov/pubmed/24807840
https://www.proquest.com/docview/1534101243
Volume 13
WOSCitedRecordID wos000337074500025&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV07T8MwED6VggQL70d5VEawBhrbSZwRhVYdIOrQoVvkxI7o0KRKUyQWfjvnPCqWCpZIlmzLOdv6PvvO3wE8ylQ6SSy45TLlWdwV0hIJd42EqKudNGXMT6tkE14YitnMn3TgYYsHn9rPy8Kp_D3lDuxSpLdm6YbfTxtXgZGQqkVRHcugbysf9LupgZ5ktZ1EVmAyOvrXMI7hsOGK5KWe3BPo6OwU9oM2RdsZFK2kCMlTgrt-vSBjuSxzo_Ixz8jIRKN_1cFuBMtjhJ4yN1f1JvaUBCaNUJYvJJGZIm8mQIME86L4yJseX5vkKSUZltWrFjxVn8N0NJwGY6tJomBJZ8BLy0aGomxfI64jVVNMOkigYlsrIX1bUuWw2GVMa41cLBFMcEG1EOnAS22qacwuoJvlmb4C4lGRiMTlvuYJZ5L60hdaDpRShmMI3oM-Gjlq9sAqqtzb1I42luvBfWv_CA1lfldmOl9jVQfBFOtw1oPLemKwWaW2EVHz6B2Podd_dX8DB8hmeBXH5d5CtyzW-g72ks9yvir6sOPNBH7DyXu_WkA_xc29XQ
linkProvider American Chemical Society
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV07T8MwED5BQSoL70d5FCOxBprYTp0RlVZBlIqhQ7fIjR3RoUmVpEgs_HbOblJYEGKMZJ8cX5Lvc-7uO4BbmUgeTwVzfKq6DvOFdETMfCMh6mueJJQGiW020R2NxGQSvFYyOaYWBhdRoKXCBvG_1QXc-0XObdin3IQt7jMbkh193q0jBkZJaqWNyh0DwrWK0M-pBoHi4ncuaTFlsPef1ezDbsUcycPK1QewodNDaPbqhm1HkNcCIyRLCH4DlnMSykWZGc2PWUoGJjf9Y5X6RvA6RCAqM_Pj3mSikp5pKpRmc0lkqsjQpGuQ3izP37LK4mPVSqUk_dLWuOAZ-xjGg_64FzpVSwVH8g4rHRf5inIDjSiPxE1RyZFOTV2thAxc6SlOpz6lWmtkZrGggglPC5F0uonraW9KT6CRZqk-A9L1RCxinwWaxYxKL5CB0LKjlDKMQ7AWtHHjouqNKCIb7PbcaL1zLbip3RDhRpnblanOljiUI7TiGEZbcLryD06z2huRZ0rg8VB6_pf5a2iG45dhNHwaPV_ADvIcZjO8_EtolPlSX8F2_F7Oirxtn6MvZknDyA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV07T8MwED5BQcDC-1EexUisgSZ-1BlRHyqiqjp06Ba5sSM6NKmSFImF387ZTSsWhBgj2SfHZ-e-y919B_CoEsXjqWSeoLrlMSGVJ2MmLIWoMDxJKA0T12yiNRzKySQcVY6irYXBRRQoqXBBfHurFzqpGAb850XOXein3IYdLpiwJ3r49bSJGlg2qRU_KvesIV4zCf2caq1QXPyOJ51d6R39d0XHcFghSPKyUvkJbJn0FPbb68ZtZ5CviUZIlhD8FiznpK8WZWa5P2Yp6dkc9c9VChzB5z4apDKzP_BtRipp2-ZCaTZXRKWaDGzaBmnP8vw9qyR2qpYqJemWrtYFfe1zGPe643bfq1oreIo3Wen5iFu0Hxq09gjgNFUcYdXUN1qq0FeB5nQqKDXGIEKLJZVMBkbKpNlK_MAEU3oBtTRLzRWQViBjGQsWGhYzqoJQhdKoptbaIg_J6tDAzYuqm1FELugd-NFm5-rwsFZFhBtlX1elJlviUI4mFscwWofLlY5wmuPgiAJbCo_O6fVf4u9hb9TpRYPX4dsNHCDcYS7RS9xCrcyX5g52449yVuQNd5S-AfOPxks
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Analysis+of+Serum+Haptoglobin+Fucosylation+in+Hepatocellular+Carcinoma+and+Liver+Cirrhosis+of+Different+Etiologies&rft.jtitle=Journal+of+proteome+research&rft.au=Zhu%2C+Jianhui&rft.au=Lin%2C+Zhenxin&rft.au=Wu%2C+Jing&rft.au=Yin%2C+Haidi&rft.date=2014-06-06&rft.pub=American+Chemical+Society&rft.issn=1535-3893&rft.eissn=1535-3907&rft.volume=13&rft.issue=6&rft.spage=2986&rft.epage=2997&rft_id=info:doi/10.1021%2Fpr500128t&rft.externalDocID=b904997066
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1535-3893&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1535-3893&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1535-3893&client=summon